Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$6,054,898
+$208,871 QoQ
Shares Held
23,841
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.53%
of 13F equity value
Holder Rank
#1,480
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PHYSICIANS FINANCIAL SERVICES, INC. holds $25,900,793 across 8 Drug Manufacturers - General names. JNJ ranks #3 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,192 | $6,227,441 | |
| 2 | AMGN |
Amgen Inc
|
16,942 | $6,135,037 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
23,841 | $6,054,898 | |
| 4 | ABBV |
AbbVie Inc.
|
12,050 | $3,032,262 | |
| 5 | NVS |
Novartis AG
|
12,234 | $1,917,312 | |
| 6 | MRK |
Merck & Co., Inc.
|
10,970 | $1,409,645 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,692 | $788,933 | |
| 8 | PFE |
Pfizer Inc
|
13,923 | $335,265 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,054,898 | 23,841 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $5,846,027 | 23,916 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $4,858,979 | 23,479 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $4,375,726 | 23,599 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $3,633,006 | 23,784 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,098,901 | 24,716 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,595,397 | 24,861 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $4,056,523 | 25,031 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $3,764,496 | 25,756 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,104,555 | 25,947 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $4,234,801 | 27,018 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $4,386,698 | 28,165 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $4,666,836 | 28,195 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $4,362,320 | 28,144 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $4,955,032 | 28,050 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $4,639,260 | 28,399 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $5,172,641 | 29,140 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $5,017,026 | 28,308 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $4,860,098 | 28,410 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $4,596,774 | 28,463 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $4,717,824 | 28,638 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $4,877,414 | 29,677 | Shares | Sole | 2021-05-21 | |
| 2020-12-31 | $4,047,184 | 25,716 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $4,253,799 | 28,572 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $3,995,438 | 28,411 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $3,488,189 | 26,601 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||